Biotechnology & Life Sciences
Brain-Interface | Genetics & DNA | Longevity
Wednesday, 3 September 2025 | 10:00 – 18:00 | Stage 3
Rapid advances across the organic and synthetic biological chain are fundamentally changing the definition of humanity today. With artificial intelligence rapidly discovering new proteins and supporting the decoding of human DNA, a genetically-engineered future becomes possible. Recent advances in genetic therapies as well used of mRNA therapies open new vistas in treatment of cancer and other diseases. And the human trials progress of brain interface companies such as Neuralink hold up the promise of revolutionary changes in rehabilitation and synthetic implants.
Keynote Speech
10:00 – 10:30
Session 1: The Longevity Revolution
10:30 – 12:00
Will we live forever? In more prosaic terms, how far are we to discovering methods for prolonging human life beyond the 100 year lifespan? What are the scientific and lifestyle reasons for ageing? Can cell damage be reduced or reversed to stop aging?
4 Speakers
First Break
12:00 – 12:30
Session 2: The Brain-Interface Revolution
12:30 – 14:00
The rapidity with which Brain-Interface technology is being clinically tested and applied in the United States and other countries raises both fears and hopes. The hope is that solutions for debilitating diseases or nervous system damage may be overcome, providing sight, mobility and other benefits to millions. The fear is that unrestricted use of Brain Interface technology may lead to a new generation of implants, creating superhuman capabilities. This sessions explores the rapid development of Brain Interface technologies and their future evolution.
4 Speakers
Second Break
14:00 – 14:30
Session 3: The Genetic Revolution
14:30 – 16:00
This session explores the transformative impact of genetic engineering on medicine, agriculture, and beyond, diving into groundbreaking technologies such as CRISPR, mRNA therapies, and gene editing. With Artificial Intelligence providing the analytical capability to decode our DNA, unlimited potential in both curing diseases as well as strengthening human biology offer themselves. Similarly there are also significant threats of unrestricted intervention in DNA.
4 Speakers
Third Break
16:00 – 16:30
Session 4: Regulating Life Sciences & Technology
16:30 – 18:00
This session explores the role of public regulation of life sciences and associated technology. It takes into account the regulatory approaches of the European Union and the United States, and provides an overview of risks and opportunities in this sector.
4 Speakers